Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-046109

Pres&Chief Investment Officer acquired 27,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sukhatme Mayukh · Pres&Chief Investment Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-27 Exercise or conversion : show line 1 in the form +27,790 3,217,750 D

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-27 Exercise or conversion : show line 2 in the form Capped Value Appreciation Rights −53,033 $6.40 $339,411 2,015,263 D
2023-09-27 Exercise or conversion : show line 3 in the form Capped Value Appreciation Rights −28,411 $11.50 $326,727 1,335,300 D
Loading xslF345X05/form4.xml…